Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmune diabetes: caught in the causality trap?

L S Gazda1, K A Gilchrist, K J Lafferty

  • 1John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia.

Immunology and Cell Biology
|December 1, 1995
PubMed
Summary

Genetics determine autoimmunity in non-obese diabetic (NOD) mice, but clinical disease development is random. Research should focus on immune pathway selection, not just infectious agents, for autoimmune disease insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production.

Journal of the peripheral nervous system : JPNS·2002
Same author

The role of CD4 and CD8 T cells in the development of autoimmune diabetes.

Journal of autoimmunity·1999
Same author

Autoimmune diabetes: the involvement of benign and malignant autoimmunity.

Journal of autoimmunity·1999
Same author

A few steps along the path to adult transplantation tolerance.

Transplantation proceedings·1999
Same author

Protection from autoimmune diabetes by adjuvant therapy in the non-obese diabetic mouse: the role of interleukin-4 and interleukin-10.

Immunology and cell biology·1998
Same author

Beta-cell replacement.

Diabetologia·1997

Area of Science:

  • Immunology
  • Genetics
  • Endocrinology

Background:

  • Genotype and clinical diabetes concordance is lacking, prompting infectious agent searches.
  • This approach overlooks autoimmunity in disease-prone individuals without clinical symptoms.

Purpose of the Study:

  • To investigate the role of genotype in autoimmune disease development.
  • To explore the factors influencing the progression of autoimmunity to clinical disease.

Main Methods:

  • Utilizing the non-obese diabetic (NOD) mouse model.
  • Observing autoimmunity expression (destructive vs. non-destructive) in genetically susceptible mice.

Main Results:

  • Genotype is a primary determinant of autoimmunity in NOD mice.

Related Experiment Videos

  • All genetically susceptible mice exhibit autoimmunity, but not all develop clinical disease.
  • The progression to clinical disease appears to be a random process influenced by immune pathway selection.

    • Conclusions:

    • Focusing solely on infectious agents for autoimmune disease may be misleading.
    • Understanding the factors that influence immune pathway selection is crucial for autoimmune disease research.
    • The random nature of clinical disease development highlights the complexity of autoimmune processes.